BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 11370934)

  • 1. Is total mass or mass of alveolar-deposited airborne particles of beryllium a better predictor of the prevalence of disease? A preliminary study of a beryllium processing facility.
    Kent MS; Robins TG; Madl AK
    Appl Occup Environ Hyg; 2001 May; 16(5):539-58. PubMed ID: 11370934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beryllium sensitization, chronic beryllium disease, and exposures at a beryllium mining and extraction facility.
    Deubner D; Kelsh M; Shum M; Maier L; Kent M; Lau E
    Appl Occup Environ Hyg; 2001 May; 16(5):579-92. PubMed ID: 11370937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure-response analysis for beryllium sensitization and chronic beryllium disease among workers in a beryllium metal machining plant.
    Madl AK; Unice K; Brown JL; Kolanz ME; Kent MS
    J Occup Environ Hyg; 2007 Jun; 4(6):448-66. PubMed ID: 17474035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of beryllium exposure to small particles at a beryllium production facility.
    Virji MA; Stefaniak AB; Day GA; Stanton ML; Kent MS; Kreiss K; Schuler CR
    Ann Occup Hyg; 2011 Jan; 55(1):70-85. PubMed ID: 20805261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison and critique of historical and current exposure assessment methods for beryllium: implications for evaluating risk of chronic beryllium disease.
    Kolanz ME; Madl AK; Kelsh MA; Kent MS; Kalmes RM; Paustenbach DJ
    Appl Occup Environ Hyg; 2001 May; 16(5):593-614. PubMed ID: 11370938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility.
    Schuler CR; Kent MS; Deubner DC; Berakis MT; McCawley M; Henneberger PK; Rossman MD; Kreiss K
    Am J Ind Med; 2005 Mar; 47(3):195-205. PubMed ID: 15712254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicochemical characteristics of aerosol particles generated during the milling of beryllium silicate ores: implications for risk assessment.
    Stefaniak AB; Chipera SJ; Day GA; Sabey P; Dickerson RM; Sbarra DC; Duling MG; Lawrence RB; Stanton ML; Scripsick RC
    J Toxicol Environ Health A; 2008; 71(22):1468-81. PubMed ID: 18836922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitization and chronic beryllium disease at a primary manufacturing facility, part 3: exposure-response among short-term workers.
    Schuler CR; Virji MA; Deubner DC; Stanton ML; Stefaniak AB; Day GA; Park JY; Kent MS; Sparks R; Kreiss K
    Scand J Work Environ Health; 2012 May; 38(3):270-81. PubMed ID: 21877099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitization and chronic beryllium disease at a primary manufacturing facility, part 1: historical exposure reconstruction.
    Virji MA; Park JY; Stefaniak AB; Stanton ML; Day GA; Kent MS; Kreiss K; Schuler CR
    Scand J Work Environ Health; 2012 May; 38(3):247-58. PubMed ID: 21850365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beryllium Exposure Control Program at the Cardiff Atomic Weapons Establishment in the United Kingdom.
    Johnson JS; Foote K; McClean M; Cogbill G
    Appl Occup Environ Hyg; 2001 May; 16(5):619-30. PubMed ID: 11370940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrafine beryllium number concentration as a possible metric for chronic beryllium disease risk.
    McCawley MA; Kent MS; Berakis MT
    Appl Occup Environ Hyg; 2001 May; 16(5):631-8. PubMed ID: 11370941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure pathway assessment at a copper-beryllium alloy facility.
    Day GA; Dufresne A; Stefaniak AB; Schuler CR; Stanton ML; Miller WE; Kent MS; Deubner DC; Kreiss K; Hoover MD
    Ann Occup Hyg; 2007 Jan; 51(1):67-80. PubMed ID: 16844720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying an apppropriate occupational exposure limit (OEL) for beryllium: data gaps and current research initiatives.
    Paustenbach DJ; Madl AK; Greene JF
    Appl Occup Environ Hyg; 2001 May; 16(5):527-38. PubMed ID: 11370933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitization and chronic beryllium disease among workers in copper-beryllium distribution centers.
    Stanton ML; Henneberger PK; Kent MS; Deubner DC; Kreiss K; Schuler CR
    J Occup Environ Med; 2006 Feb; 48(2):204-11. PubMed ID: 16474270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of Metrics of Peak Inhalation Exposure and Skin Exposure Indices With Beryllium Sensitization at a Beryllium Manufacturing Facility.
    Virji MA; Schuler CR; Cox-Ganser J; Stanton ML; Kent MS; Kreiss K; Stefaniak AB
    Ann Work Expo Health; 2019 Oct; 63(8):856-869. PubMed ID: 31504146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in dissolution behavior in a phagolysosomal simulant fluid for single-constituent and multi-constituent materials associated with beryllium sensitization and chronic beryllium disease.
    Stefaniak AB; Day GA; Hoover MD; Breysse PN; Scripsick RC
    Toxicol In Vitro; 2006 Feb; 20(1):82-95. PubMed ID: 16061346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of physicochemical properties of beryllium aerosols associated with prevalence of chronic beryllium disease.
    Stefaniak AB; Hoover MD; Day GA; Dickerson RM; Peterson EJ; Kent MS; Schuler CR; Breysse PN; Scripsick RC
    J Environ Monit; 2004 Jun; 6(6):523-32. PubMed ID: 15173904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Summary of historical beryllium uses and airborne concentration levels at Los Alamos National Laboratory.
    Stefaniak AB; Weaver VM; Cadorette M; Puckett LG; Schwartz BS; Wiggs LD; Jankowski MD; Breysse PN
    Appl Occup Environ Hyg; 2003 Sep; 18(9):708-15. PubMed ID: 12909539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant.
    Henneberger PK; Cumro D; Deubner DD; Kent MS; McCawley M; Kreiss K
    Int Arch Occup Environ Health; 2001 Apr; 74(3):167-76. PubMed ID: 11355290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface area of respirable beryllium metal, oxide, and copper alloy aerosols and implications for assessment of exposure risk of chronic beryllium disease.
    Stefaniak AB; Hoover MD; Dickerson RM; Peterson EJ; Day GA; Breysse PN; Kent MS; Scripsick RC
    AIHA J (Fairfax, Va); 2003; 64(3):297-305. PubMed ID: 12809534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.